PTAB Upholds Much Of Cannabis Epilepsy Treatment Patent
The Patent Trial and Appeal Board upheld much of a patent that involves the use of cannabinoids to treat epilepsy, handing a partial win to a unit of GW Pharmaceuticals PLC,...To view the full article, register now.
Already a subscriber? Click here to view full article